Publication | Closed Access

Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study

Hematological MalignancyOncologyMedicineMixed-phenotype Acute LeukemiaHematologyClinical TrialsMyeloid NeoplasiaPharmacotherapyPharmacologyPhase 1Japanese PatientsHealth Sciences